Cefodizime
From Wikipedia, the free encyclopedia
|
Cefodizime
|
|
| Systematic (IUPAC) name | |
| (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2- methoxyiminoacetyl]amino}-3-{[5-(carboxymethyl)- 4-methyl-1,3-thiazol-2-yl]sulfanylmethyl}-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
| Identifiers | |
| CAS number | ? |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C20H20N6O7S4 |
| Mol. mass | 584.673 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Cefodizime is a cephalosporin.
|
||||||||||||||||||||

